Back

Soluble urokinase-type plasminogen activator receptor improves risk prediction in patients with chronic heart failure

28 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Heart failure / LV dysfunction Prognosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Lorenz Koller

Medical University of Vienna, Vienna (Austria)

49 More presentations in this session

Presentation thumbnail
Doctor J. Parissis (Athens, GR)
Abstract
Presentation thumbnail
Doctor Y. Chen (Taipei, TW)
Abstract
Presentation thumbnail
Doctor C. De Pasquale (Messina, IT)
Abstract Slides
Presentation thumbnail
Doctor K. Alhabib (Riyadh, SA)
Abstract Slides
Presentation thumbnail
Doctor P. Freitas (Carnaxide, PT)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Heart failure / LV dysfunction

The Event

Event poster

ESC Congress 2016

28 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Soluble urokinase plasminogen activator surface receptor as a prognostic biomarker in heart failure
13 May 2024
thumbnail
Congress Presentation
Approaches to developing a standardized screening and intervention strategy in patients with coronary artery disease and type 2 diabetes mellitus at risk of heart failure
18 May 2025
thumbnail
Congress Presentation
Endothelial dysfunction represented by the endothelial activation and stress index (EASIX) is associated with lower overall survival in chronic heart failure patients
20 May 2023
thumbnail
Congress Presentation
Acute and chronic effects of continuous vs. interval training on soluble urokinase plasminogen activator receptor (suPAR) levels in post-myocardial infarction patients: a randomized controlled trial
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources